Christian Roth
Zinzino Independent Partner
Velkominn! Ég er sjálfstætt starfandi ráðgjafi þinn, hér til að leiðbeina þér á heilsuferðalaginu þínu.
Press releases - mánudagur, 4. febrúar 2019 15:00 CET
ZINZINO AB (PUBL): PRELIMINARY SALES REPORT JANUARY 2019
STRONG SALES GROWTH DURING JANUARY; REVENUE INCREASED 14% COMPARED WITH THE PREVIOUS YEAR.
Growth in all regions resulted in revenues for Zinzino's sales markets increasing by 24% to SEK 49.9 (40.1) million. Higher share of internal production during the month meant that Faun Pharma's external sales decreased by 50% and amounted to SEK 3.3 (6.6) million. Overall, the Group increased revenues by 14% to SEK 53.2 (46.7) million compared with the previous year.
Revenues distributed as follows:
| Regions, SEK million | Jan-19 | Jan-18 | Change |
| Nordic Countries | 33,3 | 35,9 | -7% |
| Baltic States | 4,3 | 3,7 | 17% |
| Central Europe | 12,9 | 5,0 | 157% |
| South Europe | 1,0 | 0,4 | 130% |
| North America | 1,7 | 1,7 | 5% |
| 53,2 | 46,7 | 14% |
For more information please contact:
Dag Bergheim Pettersen, CEO Zinzino, tel. +47 (0) 932 25 700 www.zinzino.se
Pictures for free publication:
Marcus Tollbom, tel. +46 (0) 70-190 03 12
Certified Adviser:
Erik Penser Bank Aktiebolag: +46 (0)8 463 83 00 Email: certifiedadviser@penser.se
Deila þessari síðu
Eða afrita hlekk